Cronos Group Inc. CRON NASDAQ · Healthcare · Canada
$3.04 -1.30% -$0.04
Summary
58 / 100 · Bulios Score
What speaks for it
- Out of every 100 USD of revenue, 28 USD is left as net profit.
- Revenue grew by 20% a year over the last 3 years.
- It holds more cash than debt: $411.2M against $1.21M.
- The share price is below the Bulios Fair Price.
What to watch
- It earns only 0.8 USD a year on every 100 USD of invested capital.
- Earnings per share swing sharply from year to year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBy our assumptions the business is worth more than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 19.6 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 26% a year over 5 years. Over the last 3 years it grew by 20% a year.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 54 USD
- Research and development 2.6 USD
- Sales and administration 40 USD
- Taxes and other -24 USD
- Net profit 28 USD
Net profit, industry median (Drug Manufacturers - Specialty & Generic) 9.9 USD
Out of every 100 USD of revenue, 28 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Neutral- Buy 3
- Hold 9
- Sell 3
Today's price within the analysts' price targets
The average target of $3.15 is 3.6% above today's price. 20% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Cannabis Flower 74%
- Cannabis Extracts 26%
- Product and Service, Other 0.3%
By region
- CANADA 62%
- ISRAEL 29%
- Other Countries 9.9%
Cannabis Flower brings in 74% of revenue. Cannabis Extracts grew fastest, by 26% a year.
Segments in detail